CRNX vs. BTSG
CRNX (Crinetics Pharmaceuticals, Inc.) and BTSG (BrightSpring Health Services, Inc) are both stocks. Both are in the Healthcare sector — CRNX in Biotechnology, BTSG in Health Information Services. Over the past year, CRNX returned 200.00% vs 204.02% for BTSG. Their 0.16 correlation means their historical movements had little consistent relationship.
Performance
CRNX vs. BTSG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRNX achieves a 79.42% return, which is significantly higher than BTSG's 59.44% return.
CRNX
- 1D
- -0.13%
- 1M
- 97.77%
- 6M
- 67.24%
- YTD
- 79.42%
- 1Y
- 200.00%
- 3Y*
- 62.54%
- 5Y*
- 35.96%
- 10Y*
- —
- ALL TIME*
- 20.04%
BTSG
- 1D
- -18.07%
- 1M
- -13.50%
- 6M
- 52.05%
- YTD
- 59.44%
- 1Y
- 204.02%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 89.48%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $220.39M | $311.69M | $243.26M | |
| $259.03M | $689.74M | $264.69M |
CRNX vs. BTSG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CRNX Crinetics Pharmaceuticals, Inc. | 79.42% | -8.96% | 37.26% |
BTSG BrightSpring Health Services, Inc | 59.44% | 119.91% | 41.92% |
Correlation
The correlation between CRNX and BTSG is 0.10, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jan 26, 2024 | 0.16 |
Fundamentals
CRNX:
$8.84B
BTSG:
$11.72B
CRNX:
-$5.09
BTSG:
$1.67
CRNX:
515.39
BTSG:
0.91
CRNX:
6.79
BTSG:
6.45
CRNX:
$15.79M
BTSG:
$14.37B
CRNX:
$16.05M
BTSG:
$1.78B
CRNX:
-$531.75M
BTSG:
$525.76M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRNX vs. BTSG — Risk / Return Rank
CRNX
BTSG
CRNX vs. BTSG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Crinetics Pharmaceuticals, Inc. (CRNX) and BrightSpring Health Services, Inc (BTSG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRNX | BTSG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.65 | ||
| Sortino ratioReturn per unit of downside risk | +0.79 | ||
| Omega ratioGain probability vs. loss probability | 1.58 | 1.60 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 4.58 | 10.52 | -5.93 |
| Martin ratioReturn relative to average drawdown | 9.07 | 59.98 | -50.91 |
Loading charts...
Drawdowns
CRNX vs. BTSG - Drawdown Comparison
The maximum CRNX drawdown since its inception was -68.70%, which is greater than BTSG's maximum drawdown of -35.56%. Use the drawdown chart below to compare losses from any high point for CRNX and BTSG.
Loading charts...
Drawdown Indicators
| CRNX | BTSG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.70% | -35.56% | -33.14% |
Max Drawdown (1Y)Largest decline over 1 year | -42.21% | -18.10% | -24.11% |
Max Drawdown (3Y)Largest decline over 3 years | -57.88% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -57.88% | — | — |
Current DrawdownCurrent decline from peak | -0.46% | -18.10% | +17.64% |
Average DrawdownAverage peak-to-trough decline | -36.98% | -7.46% | -29.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.27% | 3.22% | +18.05% |
Volatility
CRNX vs. BTSG - Volatility Comparison
Crinetics Pharmaceuticals, Inc. (CRNX) has a higher volatility of 68.84% compared to BrightSpring Health Services, Inc (BTSG) at 23.06%. This indicates that CRNX's price experiences larger fluctuations and is considered to be riskier than BTSG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRNX | BTSG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 68.84% | 23.06% | +45.78% |
Volatility (6M)Calculated over the trailing 6-month period | 76.63% | 36.11% | +40.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 113.40% | 43.83% | +69.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.55% | 45.18% | +32.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.07% | 45.18% | +28.89% |
Dividends
CRNX vs. BTSG - Dividend Comparison
Neither CRNX nor BTSG has paid dividends to shareholders.
Financials
CRNX vs. BTSG - Financials Comparison
This section allows you to compare key financial metrics between Crinetics Pharmaceuticals, Inc. and BrightSpring Health Services, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRNX and BTSG have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRNX has higher volatility (68.84%) compared to BTSG (23.06%). In terms of maximum drawdown, CRNX dropped -68.70% vs BTSG's -35.56%.
BTSG currently has the higher Sharpe Ratio (4.36 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRNX and BTSG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer